LACTB and tuberculosis: As beta-lactam resistance is a well-established phenomenon dating back to 1929 [7], and the most effective mechanism for bacteria to counteract beta-lactam antibiotics is via the production of beta-lactamases [8], the addition of a beta-lactamase inhibitor such as clavulanate can reduce the incidence of drug-resistance to increase the utility of beta-lactam therapy for TB.